The addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients: a single-center experience. Issue 7 (7th June 2022) - Bennett, Rory; Chan, Henry; Henderson, Ross; Merriman, Eileen; Hanna, Merit; Elinder-Camburn, Anna; Simpson, David